Can Breo Make Asthma Worse?
Asthma is a chronic respiratory condition that affects millions of people worldwide. It is characterized by inflammation and narrowing of the airways, leading to symptoms such as coughing, wheezing, shortness of breath, and chest tightness. While there are various medications available to manage asthma, one common concern among patients is whether certain treatments, like Breo, can worsen their condition. In this article, we will explore the potential risks and benefits of using Breo for asthma management.
Breo (fluticasone propionate and vilanterol) is a combination inhaler that contains a corticosteroid and a long-acting beta-agonist. The corticosteroid, fluticasone propionate, helps reduce airway inflammation, while the long-acting beta-agonist, vilanterol, helps relax the muscles around the airways, making it easier to breathe. This combination makes Breo an effective treatment for maintaining asthma control in many patients.
However, some patients may worry that Breo could make their asthma worse. While it is true that any medication can have side effects, the risk of Breo exacerbating asthma symptoms is relatively low. In fact, research has shown that Breo is generally safe and well-tolerated when used as directed by a healthcare professional.
One concern regarding Breo is the potential for paradoxical bronchospasm, a rare but serious side effect that can cause the airways to constrict instead of relax. This can lead to worsening asthma symptoms, including sudden onset of severe shortness of breath. However, paradoxical bronchospasm is an extremely rare occurrence, and most patients who use Breo do not experience this side effect.
Another concern is the potential for increased risk of infections, such as pneumonia, due to the use of corticosteroids. While corticosteroids can weaken the immune system, research has shown that the risk of infections is low when Breo is used at recommended doses. Additionally, healthcare professionals closely monitor patients taking corticosteroids to ensure they are using the lowest effective dose.
It is important to note that Breo is not a rescue inhaler, meaning it is not intended to relieve acute asthma symptoms. Instead, it is a maintenance medication designed to prevent asthma symptoms and reduce the frequency of asthma attacks. For patients with well-controlled asthma, Breo can be an effective long-term treatment option.
In conclusion, while Breo is a commonly prescribed asthma medication, there is a low risk of it making asthma worse. Patients should discuss their concerns with their healthcare provider, who can help determine whether Breo is an appropriate treatment option for their specific asthma needs. By using Breo as directed and maintaining regular follow-up with a healthcare professional, patients can safely manage their asthma and minimize the risk of exacerbations.
